ALSFRS-R decline rate prior to baseline is not useful for stratifying subsequent progression of functional decline

.

Source: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration - February 7, 2024 Category: Neurology Authors: Tatsuto HamataniNaoki AtsutaFumiya SanoRyoichi NakamuraYukikazu HayashiGen Sobue1 Drug Development Division, Sumitomo Pharma Co., Ltd, Tokyo, Japan2 Clinical Research, Sumitomo Pharma America, Inc, USA3 Department of Neurology, Aichi Medical University Sc Source Type: research